The non-receptor tyrosine kinase, Fyn, has recently been implicated in the pathogenesis of AD, which is mainly based on its neuropathogenic role that links Aβ toxicity to tau pathology9, 10. This evidence concerns the gene MAPT and Alzheimer disease.